RECOMBINANT HUMAN GROWTH HORMONE ( DrugBank: Growth hormone, Human growth hormone, Recombinant human growth hormone )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
78	下垂体前葉機能低下症	129
193	プラダー・ウィリ症候群	3
265	脂肪萎縮症	2

78. 下垂体前葉機能低下症

臨床試験数 : 494 / 薬物数 : 385 - (DrugBank : 49) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 100

diseases per page:

Showing 1 to 10 of 129 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100048579	2021-08-01	2021-07-11	Efficacy and Safety of JINTROLONG for Transitional Growth Hormone Deficiency	Efficacy and Safety of JINTROLONG for Transitional Growth Hormone Deficiency (TGHD)	Transitional Growth Hormone Deficiency	Experimental group:polyethylene glycol recombinant human growth hormone injection;	The Children's Hospital of Zhejiang University School of Medicine	NULL	Pending		26	Both	Experimental group:23;	Phase 4	China
2	EUCTR2020-000874-92-PL (EUCTR)	22/03/2021	26/10/2020	A Multicenter, 12-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Dail ...	A Multicenter, 12-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Dail ...	Growth hormone deficiency MedDRA version: 20.0;Level: PT;Classification code 10056438;Term: Growth h ...	Product Name: LUM-201 INN or Proposed INN: Ibutamoren mesilate Other descriptive name: IBUTAMOREN MESI ...	Lumos Pharma, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80	Phase 2	United States;Poland;Ukraine;Australia;Russian Federation;Israel;New Zealand
3	ChiCTR2000039505	2020-12-01	2020-10-30	An exploratory study of recombinant growth hormone in improving sexual dysfunction in male adult pat ...	An exploratory study of recombinant growth hormone in improving sexual dysfunction in male adult pat ...	Adult growth hormone deficiency	experimental group:Recombinant Human Growth Hormone;	Huashan Hospital Affiliated to Fudan University	NULL	Recruiting	18	50	Male	experimental group:20;		China
4	NCT04020913 (ClinicalTrials.gov)	July 22, 2019	24/5/2019	Skeletal Muscle Effects of GH in Boys	Recombinant Human Growth Hormone(GH): Effects on Metabolic Profile, Body Composition and Skeletal Mu ...	Growth Hormone Deficiency;Idiopathic Short Stature	Drug: Somatropin injection	Nemours Children's Clinic	Novo Nordisk A/S	Recruiting	6 Years	11 Years	Male	45		United States
5	EUCTR2017-003410-20-IT (EUCTR)	30/10/2018	11/10/2018	A long-term extension trial of TransCon hGH, a sustained-release recombinant human growth hormonepro ...	enliGHten: A Multicenter, Phase 3, Long-term, Open-label Trial Investigating Safety and Efficacy of ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) INN or Proposed INN: lonapegsomatropin Other descriptive name: TR ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	400	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Belarus;Greece;Ukraine;Turkey;Russian Federation;Italy;Armenia;Canada;Poland;Romania;A ...
6	EUCTR2017-003410-20-PL (EUCTR)	23/10/2018	08/11/2018	A long-term extension trial of TransCon hGH, a sustained-release recombinant human growth hormonepro ...	enliGHten: A Multicenter, Phase 3, Long-term, Open-label Trial Investigating Safety and Efficacy of ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) INN or Proposed INN: lonapegsomatropin Other descriptive name: TR ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	Belarus;United States;Greece;Ukraine;Turkey;Russian Federation;Italy;Armenia;Canada;Poland;Romania;A ...
7	EUCTR2017-003410-20-GR (EUCTR)	04/06/2018	19/04/2018	A long-term extension trial of TransCon hGH, a sustained-release recombinant human growth hormonepro ...	enliGHten: A Multicenter, Phase 3, Long-term, Open-label Trial Investigating Safety and Efficacy of ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) INN or Proposed INN: lonapegsomatropin Other descriptive name: TR ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	United States;Belarus;Greece;Ukraine;Turkey;Russian Federation;Italy;Armenia;Canada;Poland;Romania;A ...
8	EUCTR2017-003410-20-BG (EUCTR)	20/04/2018	09/01/2018	A long-term extension trial of TransCon hGH, a sustained-release recombinant human growth hormonepro ...	enliGHten: A Multicenter, Phase 3, Long-term, Open-label Trial Investigating Safety and Efficacy of ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) INN or Proposed INN: lonapegsomatropin Other descriptive name: TR ...	Ascendis Pharma Endocrinology Division A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	United States;Belarus;Greece;Ukraine;Turkey;Russian Federation;Italy;Armenia;Canada;Poland;Romania;A ...
9	EUCTR2016-001145-11-DE (EUCTR)	12/02/2018	14/12/2016	A trial of TransCon hGH, a sustained-release recombinant human growth hormoneproduct, for treatment ...	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 20.0;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) - 12.1mg INN or Proposed INN: lonapegsomatropin Other descriptive ...	Ascendis Pharma Endocrinology Division A/S	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Lebanon;Russian Federation;Chile;Azerbaijan;Italy;France;Jordan;Australia;South Africa;Lithuania;Tur ...
10	EUCTR2016-001145-11-GR (EUCTR)	28/03/2017	02/02/2017	A trial of TransCon hGH, a sustained-release recombinant human growth hormoneproduct, for treatment ...	A multicenter, Phase 3, randomized, open-label, active-controlled, parallel-group trial investigatin ...	Growth hormone deficiency (GHD) in prepubertal children MedDRA version: 19.1;Level: PT;Classificatio ...	Product Name: TransCon hGH (ACP-011) - 12,1mg INN or Proposed INN: TransCon hGH (ACP-011) Other descri ...	Ascendis Pharma Endocrinology Division A/S	NULL	Not Recruiting			Female: yes Male: yes	150	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Belarus;United States;Greece;Kyrgyzstan;Spain;Ukraine;Lebanon;Russian Federation;Chile;Azerbaijan;It ...

First Previous1 2 3 4 5…13Next Last

先頭へ

193. プラダー・ウィリ症候群

臨床試験数 : 111 / 薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100046551	2021-05-18	2021-05-21	Multimodal magnetic resonance imaging changes in Prader-Willi syndrome before and after growth hormo ...	Application of multimodal magnetic resonance imaging in pre - and post-treatment evaluation of recom ...	Prader-Willi sydrome	Prader-Willi sydrome group treated with rhGH:Treat with rhGH;Prader-Willi sydrome group treated with ...	Cai Jinhua	NULL	Recruiting	0	16	Both	Prader-Willi sydrome group treated with rhGH:40;Prader-Willi sydrome group treated without rhGH:40;Normal development group:40;	N/A	China
2	NCT03554031 (ClinicalTrials.gov)	April 14, 2018	30/5/2018	A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth HormoneInjection in Patients ...	A Single Arm, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Recombinan ...	Prader-Willi Syndrome	Drug: Recombinant Human Growth Hormone (rhGH) Injection	GeneScience Pharmaceuticals Co., Ltd.	Children's Hospital of Fudan University;Tongji medical college huazhong university of science & tech ...	Unknown status	1 Month	5 Years	All	30	Phase 3	China
3	EUCTR2017-002164-41-ES (EUCTR)	03/07/2017	21/06/2017	Study with adult patients with Prader-Willi syndrome, which evaluate the effect of growth hormone th ...	Growth hormone therapy in adults with Prader-Willi syndrome: Effect on muscle tone assessed by funct ...	Patients with Prader-Willi Syndrome (SPW) with Growth hormone deficit. MedDRA version: 20.0;Level: P ...	Trade Name: Genotonorm Miniquick 0,2 mg INN or Proposed INN: RECOMBINANT HUMAN GROWTH HORMON Other des ...	Fundació Parc Taulí	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Spain

First Previous1Next Last

265. 脂肪萎縮症

臨床試験数 : 116 / 薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00130286 (ClinicalTrials.gov)	March 2005	12/8/2005	Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistanc ...	Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Human G ...	HIV-Associated Lipodystrophy Syndrome;Insulin Resistance;HIV Infections;Metabolic Syndrome X;Body We ...	Drug: Rosiglitazone;Drug: Recombinant human growth hormone + rosiglitazone	Weill Medical College of Cornell University	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	18 Years	65 Years	All	77	Phase 1/Phase 2	United States
2	NCT00100698 (ClinicalTrials.gov)	January 2004	4/1/2005	Physiologic Growth Hormone Effects in HIV Lipodystrophy	Physiologic Growth Hormone Effects in HIV Lipodystrophy	AIDS;HIV Infections	Drug: recombinant human growth hormone;Drug: placebo	Massachusetts General Hospital	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	18 Years	60 Years	All	56	N/A	United States

First Previous1Next Last

先頭へ